Casdin Capital as of March 31, 2023
Portfolio Holdings for Casdin Capital
Casdin Capital holds 40 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biolife Solutions Com New (BLFS) | 13.6 | $165M | 7.6M | 21.75 | |
| Sarepta Therapeutics (SRPT) | 13.5 | $163M | 1.2M | 137.83 | |
| Relay Therapeutics (RLAY) | 7.7 | $94M | 5.7M | 16.47 | |
| Eqrx | 6.3 | $77M | 40M | 1.94 | |
| Illumina (ILMN) | 5.3 | $64M | 275k | 232.55 | |
| Alnylam Pharmaceuticals (ALNY) | 4.5 | $54M | 270k | 200.32 | |
| Intellia Therapeutics (NTLA) | 3.9 | $48M | 1.3M | 37.27 | |
| Pliant Therapeutics (PLRX) | 3.7 | $45M | 1.7M | 26.60 | |
| Revolution Medicines (RVMD) | 3.2 | $39M | 1.8M | 21.66 | |
| EXACT Sciences Corporation (EXAS) | 3.2 | $38M | 565k | 67.81 | |
| Genedx Holdings Corp Com Cl A | 3.1 | $37M | 102M | 0.36 | |
| Somalogic Class A Com | 2.6 | $32M | 13M | 2.55 | |
| Verve Therapeutics (VERV) | 2.5 | $31M | 2.1M | 14.42 | |
| Blueprint Medicines (BPMC) | 2.5 | $30M | 670k | 44.99 | |
| Denali Therapeutics (DNLI) | 2.5 | $30M | 1.3M | 23.04 | |
| Maxcyte (MXCT) | 2.0 | $24M | 4.9M | 4.95 | |
| 2seventy Bio Common Stock (TSVT) | 1.7 | $21M | 2.0M | 10.20 | |
| Abcellera Biologics (ABCL) | 1.6 | $19M | 2.5M | 7.54 | |
| Mirati Therapeutics | 1.6 | $19M | 510k | 37.18 | |
| 4d Molecular Therapeutics In (FDMT) | 1.5 | $18M | 1.1M | 17.19 | |
| Beam Therapeutics (BEAM) | 1.4 | $18M | 570k | 30.62 | |
| Tenaya Therapeutics (TNYA) | 1.4 | $17M | 6.1M | 2.85 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.3 | $16M | 677k | 23.79 | |
| Prometheus Biosciences | 1.3 | $16M | 150k | 107.32 | |
| Avidity Biosciences Ord (RNA) | 1.1 | $13M | 850k | 15.35 | |
| Fate Therapeutics (FATE) | 1.0 | $12M | 2.1M | 5.70 | |
| Century Therapeutics (IPSC) | 0.9 | $11M | 3.2M | 3.47 | |
| Twist Bioscience Corp (TWST) | 0.9 | $11M | 700k | 15.08 | |
| Absci Corp (ABSI) | 0.8 | $9.4M | 5.4M | 1.75 | |
| Prime Medicine (PRME) | 0.7 | $9.0M | 734k | 12.30 | |
| Dice Therapeutics | 0.7 | $8.9M | 310k | 28.65 | |
| Optimizerx Corp Com New (OPRX) | 0.6 | $7.3M | 500k | 14.63 | |
| Incyte Corporation (INCY) | 0.5 | $5.6M | 78k | 72.27 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $4.0M | 511k | 7.79 | |
| Tango Therapeutics (TNGX) | 0.3 | $4.0M | 1.0M | 3.95 | |
| Singular Genomics Systems In | 0.1 | $1.6M | 1.3M | 1.21 | |
| Invitae (NVTAQ) | 0.1 | $1.4M | 1.0M | 1.35 | |
| Exscientia Ads (EXAI) | 0.1 | $1.1M | 214k | 5.30 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $403k | 206k | 1.95 | |
| Kronos Bio (KRON) | 0.0 | $181k | 124k | 1.46 |
